GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Selling, General, & Admin. Expense

Psyence Biomedical (Psyence Biomedical) Selling, General, & Admin. Expense : $ Mil (TTM As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Psyence Biomedical's selling, general, & admin. expense for the six months ended in Mar. 2023 was $1.57 Mil. Psyence Biomedical does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2023.


Psyence Biomedical Selling, General, & Admin. Expense Historical Data

The historical data trend for Psyence Biomedical's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Selling, General, & Admin. Expense Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Selling, General, & Admin. Expense
- 1.70 1.57

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Selling, General, & Admin. Expense - 1.70 1.57

Competitive Comparison of Psyence Biomedical's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Psyence Biomedical's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Selling, General, & Admin. Expense falls into.



Psyence Biomedical Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.


Psyence Biomedical  (NAS:PBM) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Psyence Biomedical Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines